BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND DICER1, Dicer, 23405, ENSG00000100697, KIAA0928, HERNA, Q9UPY3, K12H4_8-LIKE AND Prognosis
22 results:

  • 1. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of dicer to accelerate triple-negative breast cancer progression.
    Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
    Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Pleuropneumoblastoma: a case report about a rare pediatric tumor].
    Namaoui RY; Hadjaoui W; Zerabib A; Belbekri L; Zar F; Berrah H; Mouats A; Bessaïh A
    Pan Afr Med J; 2022; 43():8. PubMed ID: 36284883
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Outcomes for Children With Type II and Type III Pleuropulmonary Blastoma Following Chemotherapy: A Report From the International PPB/
    Schultz KAP; Harris AK; Nelson AT; Watson D; Lucas JT; Miniati D; Stewart DR; Hagedorn KN; Mize W; Kamihara J; Mitchell SG; Wilson DB; Gettinger K; Rangaswami AA; Harney LA; Rodriguez Galindo C; Bisogno G; Dehner LP; Hill DA; Messinger YH
    J Clin Oncol; 2023 Feb; 41(4):778-789. PubMed ID: 36137255
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel genetic characteristics in low-grade fetal adenocarcinoma of the lung.
    Zhang S; Yin H; Zhang J; Yang L; Yang G; Jia J; Jiao Y; Ying J; Wang Y
    Thorac Cancer; 2021 Oct; 12(20):2789-2795. PubMed ID: 34464028
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Type II Pleuropulmonary Blastoma in a 4 Month Old Infant with Negative dicer1 Mutation on Next Generation Sequencing.
    Spahiu L; Baruti-Gafurri Z; Grajçevci-Uka V; Salihu S; Maqastena R; Behluli E
    Med Arch; 2021 Feb; 75(1):61-65. PubMed ID: 34012202
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Expression of p53 is significantly associated with recurrence-free survival and overall survival in pleuropulmonary blastoma (PPB): a report from the International Pleuropulmonary Blastoma/dicer1 Registry.
    González IA; Mallinger P; Watson D; Harris AK; Messinger YH; Schultz KAP; Field A; Hill DA; Dehner LP
    Mod Pathol; 2021 Jun; 34(6):1104-1115. PubMed ID: 33637876
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Pleuropulmonary Blastoma with Hotspot Mutations in RNase IIIb Domain of dicer 1: Clinicopathologic Study of 10 Cases in a Single-Institute Experience.
    Lee M; Kim TI; Jang SJ; Cho KJ; Lee SM; Kim HR; Song JS
    Pathobiology; 2021; 88(3):251-260. PubMed ID: 33567437
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Hereditary ovarian tumour syndromes: current update on genetics and imaging.
    Shanbhogue KP; Prasad AS; Ucisik-Keser FE; Katabathina VS; Morani AC
    Clin Radiol; 2021 Apr; 76(4):313.e15-313.e26. PubMed ID: 33353730
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diagnosis and treatment of pleuropulmonary blastoma in children: A single-center report of 41 cases.
    Zhang N; Zeng Q; Ma X; Chen C; Yu J; Zhang X; Yan D; Xu C; Liu D; Zhang Q
    J Pediatr Surg; 2020 Jul; 55(7):1351-1355. PubMed ID: 31277979
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic value of plasma expression of microRNAs complementary to Drosha and dicer in lung cancer patients.
    Szczyrek M; Kuźnar-Kamińska B; Grenda A; Krawczyk P; Sawicki M; Głogowski M; Balicka G; Rolska-Kopińska A; Nicoś M; Jakimiec M; Batura-Gabryel H; Kowalski DM; Mlak R; Krzakowski M; Milanowski J
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3857-3866. PubMed ID: 31115013
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Predictive value of microRNA let-7a expression for efficacy and prognosis of radiotherapy in patients with lung cancer brain metastasis: A case-control study.
    Liu JK; Liu HF; Ding Y; Gao GD
    Medicine (Baltimore); 2018 Nov; 97(44):e12847. PubMed ID: 30383637
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Pleuropulmonary Blastoma: A Single-center Case Series of 6 Patients.
    Pierce JM; LaCroix P; Heym K; Bowman WP; Margraf L; Iglesias J; Ray A
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e419-e422. PubMed ID: 28991133
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The prevalence of dicer1 pathogenic variation in population databases.
    Kim J; Field A; Schultz KAP; Hill DA; Stewart DR
    Int J Cancer; 2017 Nov; 141(10):2030-2036. PubMed ID: 28748527
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. dicer suppresses MMP-2-mediated invasion and VEGFA-induced angiogenesis and serves as a promising prognostic biomarker in human clear cell renal cell carcinoma.
    Chen YS; Meng F; Li HL; Liu QH; Hou PF; Bai J; Zheng JN
    Oncotarget; 2016 Dec; 7(51):84299-84313. PubMed ID: 27732931
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pleuropulmonary blastoma: a report on 350 central pathology-confirmed pleuropulmonary blastoma cases by the International Pleuropulmonary Blastoma Registry.
    Messinger YH; Stewart DR; Priest JR; Williams GM; Harris AK; Schultz KA; Yang J; Doros L; Rosenberg PS; Hill DA; Dehner LP
    Cancer; 2015 Jan; 121(2):276-85. PubMed ID: 25209242
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Suppression of dicer increases sensitivity to gefitinib in human lung cancer cells.
    Chen JC; Su YH; Chiu CF; Chang YW; Yu YH; Tseng CF; Chen HA; Su JL
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S555-63. PubMed ID: 24723223
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. dicer1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
    Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
    Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.
    Dehner LP; Jarzembowski JA; Hill DA
    Mod Pathol; 2012 Apr; 25(4):602-14. PubMed ID: 22157934
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis.
    Tan X; Qin W; Zhang L; Hang J; Li B; Zhang C; Wan J; Zhou F; Shao K; Sun Y; Wu J; Zhang X; Qiu B; Li N; Shi S; Feng X; Zhao S; Wang Z; Zhao X; Chen Z; Mitchelson K; Cheng J; Guo Y; He J
    Clin Cancer Res; 2011 Nov; 17(21):6802-11. PubMed ID: 21890451
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A precursor microRNA in a cancer cell nucleus: get me out of here!
    Melo SA; Esteller M
    Cell Cycle; 2011 Mar; 10(6):922-5. PubMed ID: 21346411
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.